The Salk Institute for Biological Studies

The Salk Institute for Biological Studies

The Salk Institute for Biological Studies

Overview
Date Founded

1960

Headquarters

10010 N TORREY PINES RD, LA JOLLA, CA, 92037, USA

Charitable Causes

Biological & Life Science Research
Philanthropy, Voluntarism, and Grantmaking Foundations
Neurology & Neuroscience
Education Research & Support

Employees (Worldwide)

1,081

Industries

Hospitals & Patient Services
Consumer Services
Schools & Student Services

Company Description

The Salk Institute for Biological Studies is an independent, non-profit, scientific research institute located in La Jolla, California. It was founded in 1960 by Jonas Salk, the developer of the polio vaccine; among the founding consultants were Jacob Bronowski and Francis Crick. Building did not start until spring of 1962. The institute consistently ranks among the top institutions in the US in terms of research output and quality in the life sciences

Contact Data
Trying to get in touch with decision makers at The Salk Institute for Biological Studies? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Assistant Secretary/General Counsel

President

Chief Financial Officer

General Counsel, General Counsel

Senior Director, OFC of Tech Development

Associate Director of Shared Resources, Salk Cancer Center

President Emerita

Benefit Plan Administrator

Vice President, External Relations

Vice President, Academic & Administrative Services

Board of Directors

Chair at The Salk Institute for Biological Studies

Distinguished Alumni
Robert Hershberg is now Executive Vice President, Head of Business Development & Global Alliances at Celgene Corp.
Jackie Papkoff is now Senior Vice President, Chief Scientific Officer Microbiome at Assembly Biosciences, Inc.
Paths to The Salk Institute for Biological Studies
Potential Connections via
Relationship Science
You
The Salk Institute for Biological Studies
Advisors & Consultants
Legal Advisor

Cooley LLP is a provider of strategic litigation and business transaction services and is a representative of private and public companies, financial institutions, venture capital firms and nonprofit organizations. The company was founded in 1920 and is headquartered in New York, NY.

Legal Advisor
Auditor

Treasurer at San Diego Police Foundation

Legal Advisor

Partner at Allen Matkins Leck Gamble Mallory & Natsis LLP

Clients

Celldex Therapeutics, Inc. engages in the research, development, and commercialization of immunotherapies and other targeted biologics. Its drug candidates have the ability to engage the human immune system and directly inhibit tumors to treat specific types of cancer and other diseases. Its pipeline includes Varlilumab, CDX-1140, and CDX-301, and CDX-3379. The company was founded by Anthony S. Marucci and Tibor Keler in 1983 and is headquartered in Hampton, NJ.

At Acceleron, we aim to transform the lives of people suffering from cancer and orphan diseases by discovering and developing innovative therapies. Acceleron scientists have world-leading expertise in developing medicines that regulate the transforming growth factor beta (TGF-ß) superfamily of proteins, which play fundamental roles in the growth and repair of cells and tissues such as red blood cells, bone, and blood vessels. Based on this expertise, we have built a robust pipeline of biologic therapies targeted to key mechanisms underlying blood diseases and cancer. Since our founding in 2004, Acceleron has brought four distinct, internally-discovered, developed and manufactured products into clinical trials, and has established collaborations with leading biopharmaceutical companies and research institutions to bring these products to the patients who need them.

Key Stats and Financials As of 2016
Market Capitalization
Total Enterprise Value
Earnings Per Share
Revenue
$128M
Non-Profit Donations & Grants Received
Investors
Details Hidden

NIH is the largest source of funding for medical research in the world, creating hundreds of thousands of high-quality jobs by funding thousands of scientists in universities and research institutions in every state across America and around the globe. NIH is made up of 27 Institutes and Centers, each with a specific research agenda, often focusing on particular diseases or body systems. NIH leadership plays an active role in shaping the agency's research planning, activities, and outlook. The Office of the Director is the central office at NIH, responsible for setting policy for NIH and for planning, managing, and coordinating the programs and activities of all the NIH components. The NIH Director, with a unique and critical perspective on the entire agency, is responsible for providing leadership to the Institutes and for constantly identifying needs and opportunities, especially for efforts that involve multiple Institutes. The NIH Director is assisted by the NIH Deputy Directors including the Principal Deputy Director, who shares in the overall direction of the agency's activities. NIH is responsive to Congressional legislation that adjusts NIH's programs to meet changing research needs. As a result of the NIH reauthorization process, NIH is able to respond strategically in an era when medical research requires constant innovation and increased interdisciplinary efforts. More than 80% of the NIH's budget goes to more than 300,000 research personnel at over 2,500 universities and research institutions. In addition, about 6,000 scientists work in NIH’s own Intramural Research laboratories, most of which are on the NIH main campus in Bethesda, Maryland. The main campus is also home to the NIH Clinical Center, the largest hospital in the world totally dedicated to clinical research. Successful biomedical research depends on the talent and dedication of the scientific workforce. NIH supports many innovative training programs and funding mechanisms that foster scientific creativity and exploration. The goal is to strengthen our nation’s research capacity, broaden our research base, and inspire a passion for science in current and future generations of researchers. NIH encourages and depends on public involvement in federally supported research and activities. NIH’s wide-ranging public efforts include outreach and education, nationwide events, requests for public input on NIH projects, and special programs designed specifically to involve public representatives in clinical research

Suppliers
BioNano Genomics, Inc. Computer Software | San Diego, CA

BioNano Genomics, Inc. is a life sciences instrumentation company, which focuses on genome analysis space. The firm engages in the development and marketing of Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline cytogenetics. The company was founded by Han Cao in October 2003 and is headquartered in San Diego, CA.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by The Salk Institute for Biological Studies. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of The Salk Institute for Biological Studies's profile does not indicate a business or promotional relationship of any kind between RelSci and The Salk Institute for Biological Studies.
  • be_ixf; php_sdk; php_sdk_1.4.15
  • https://relationshipscience.com/organization/the-salk-institute-for-biological-studies-28078
  • https://relationshipscience.com/organization/the-salk-institute-for-biological-studies-28078